newsfilter
← Latest News
GlobeNewswire·

FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million

Purchase price represents enterprise value of $85 million plus FibroGen net cash held in China at closing, currently estimated to be approximately $75 millionUpon close, FibroGen will repay its term loan to Morgan